nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—EIF2AK1—liver—celiac disease	0.00144	0.00319	CbGeAlD
Bosutinib—MAP4K1—lymphoid tissue—celiac disease	0.00144	0.00318	CbGeAlD
Bosutinib—PTK2—connective tissue—celiac disease	0.00143	0.00317	CbGeAlD
Bosutinib—BTK—lymphoid tissue—celiac disease	0.00143	0.00317	CbGeAlD
Bosutinib—STK24—blood—celiac disease	0.00143	0.00316	CbGeAlD
Bosutinib—PTK2B—smooth muscle tissue—celiac disease	0.00142	0.00315	CbGeAlD
Bosutinib—STK35—pancreas—celiac disease	0.00141	0.00313	CbGeAlD
Bosutinib—CSK—pancreas—celiac disease	0.00141	0.00311	CbGeAlD
Bosutinib—ERBB3—epithelium—celiac disease	0.0014	0.0031	CbGeAlD
Bosutinib—VRK2—liver—celiac disease	0.0014	0.00309	CbGeAlD
Bosutinib—FES—liver—celiac disease	0.0014	0.00309	CbGeAlD
Bosutinib—CSNK1A1—pancreas—celiac disease	0.0014	0.00309	CbGeAlD
Bosutinib—MAP4K2—lymphoid tissue—celiac disease	0.00139	0.00308	CbGeAlD
Bosutinib—CLK1—pancreas—celiac disease	0.00139	0.00307	CbGeAlD
Bosutinib—FER—blood—celiac disease	0.00138	0.00306	CbGeAlD
Bosutinib—ALK—blood—celiac disease	0.00138	0.00306	CbGeAlD
Bosutinib—RPS6KB1—connective tissue—celiac disease	0.00138	0.00305	CbGeAlD
Bosutinib—LYN—blood—celiac disease	0.00137	0.00304	CbGeAlD
Bosutinib—TNIK—liver—celiac disease	0.00137	0.00303	CbGeAlD
Bosutinib—AXL—connective tissue—celiac disease	0.00136	0.00302	CbGeAlD
Bosutinib—CAMK2G—pancreas—celiac disease	0.00136	0.00301	CbGeAlD
Bosutinib—PTK2—epithelium—celiac disease	0.00136	0.00301	CbGeAlD
Bosutinib—CDK2—liver—celiac disease	0.00136	0.003	CbGeAlD
Bosutinib—ROCK1—lymphoid tissue—celiac disease	0.00135	0.003	CbGeAlD
Bosutinib—MAP4K1—blood—celiac disease	0.00135	0.00299	CbGeAlD
Bosutinib—MAP2K2—smooth muscle tissue—celiac disease	0.00135	0.00298	CbGeAlD
Bosutinib—BTK—blood—celiac disease	0.00135	0.00298	CbGeAlD
Bosutinib—STK26—liver—celiac disease	0.00134	0.00297	CbGeAlD
Bosutinib—ROCK1—digestive system—celiac disease	0.00134	0.00296	CbGeAlD
Bosutinib—MAP3K7—smooth muscle tissue—celiac disease	0.00133	0.00293	CbGeAlD
Bosutinib—BMPR2—lymphoid tissue—celiac disease	0.00132	0.00291	CbGeAlD
Bosutinib—PTK2—smooth muscle tissue—celiac disease	0.00131	0.0029	CbGeAlD
Bosutinib—MAP4K2—blood—celiac disease	0.00131	0.00289	CbGeAlD
Bosutinib—RPS6KB1—epithelium—celiac disease	0.00131	0.00289	CbGeAlD
Bosutinib—EPHB4—connective tissue—celiac disease	0.0013	0.00288	CbGeAlD
Bosutinib—BMPR2—digestive system—celiac disease	0.0013	0.00287	CbGeAlD
Bosutinib—CSNK1E—pancreas—celiac disease	0.00129	0.00286	CbGeAlD
Bosutinib—STK3—blood—celiac disease	0.00129	0.00286	CbGeAlD
Bosutinib—MERTK—lymphoid tissue—celiac disease	0.00129	0.00285	CbGeAlD
Bosutinib—EPHB3—digestive system—celiac disease	0.00129	0.00285	CbGeAlD
Bosutinib—DMPK—liver—celiac disease	0.00129	0.00285	CbGeAlD
Bosutinib—WEE1—liver—celiac disease	0.00129	0.00285	CbGeAlD
Bosutinib—IRAK1—smooth muscle tissue—celiac disease	0.00128	0.00284	CbGeAlD
Bosutinib—FYN—connective tissue—celiac disease	0.00128	0.00282	CbGeAlD
Bosutinib—ROCK1—blood—celiac disease	0.00127	0.00282	CbGeAlD
Bosutinib—SIK1—pancreas—celiac disease	0.00127	0.00282	CbGeAlD
Bosutinib—MAP4K4—lymphoid tissue—celiac disease	0.00127	0.0028	CbGeAlD
Bosutinib—RPS6KB1—smooth muscle tissue—celiac disease	0.00126	0.00279	CbGeAlD
Bosutinib—BCR—lymphoid tissue—celiac disease	0.00126	0.00278	CbGeAlD
Bosutinib—MAP4K4—digestive system—celiac disease	0.00125	0.00277	CbGeAlD
Bosutinib—ERBB3—pancreas—celiac disease	0.00125	0.00276	CbGeAlD
Bosutinib—AXL—smooth muscle tissue—celiac disease	0.00125	0.00276	CbGeAlD
Bosutinib—MAP2K2—pancreas—celiac disease	0.00125	0.00275	CbGeAlD
Bosutinib—CYP3A4—urine—celiac disease	0.00124	0.00275	CbGeAlD
Bosutinib—EPHB4—epithelium—celiac disease	0.00124	0.00274	CbGeAlD
Bosutinib—STK25—liver—celiac disease	0.00123	0.00272	CbGeAlD
Bosutinib—STK36—blood—celiac disease	0.00123	0.00272	CbGeAlD
Bosutinib—MAP2K1—lymphoid tissue—celiac disease	0.00122	0.0027	CbGeAlD
Bosutinib—CSK—lymphoid tissue—celiac disease	0.00122	0.00269	CbGeAlD
Bosutinib—MERTK—blood—celiac disease	0.00121	0.00268	CbGeAlD
Bosutinib—EPHA2—epithelium—celiac disease	0.00121	0.00268	CbGeAlD
Bosutinib—TBK1—pancreas—celiac disease	0.00121	0.00268	CbGeAlD
Bosutinib—PTK2—pancreas—celiac disease	0.00121	0.00268	CbGeAlD
Bosutinib—MAP2K1—digestive system—celiac disease	0.00121	0.00267	CbGeAlD
Bosutinib—CSNK1A1—lymphoid tissue—celiac disease	0.00121	0.00267	CbGeAlD
Bosutinib—CSK—digestive system—celiac disease	0.0012	0.00265	CbGeAlD
Bosutinib—HCK—lymphoid tissue—celiac disease	0.0012	0.00265	CbGeAlD
Bosutinib—CLK1—lymphoid tissue—celiac disease	0.0012	0.00265	CbGeAlD
Bosutinib—PLK2—liver—celiac disease	0.0012	0.00264	CbGeAlD
Bosutinib—CSNK1A1—digestive system—celiac disease	0.00119	0.00264	CbGeAlD
Bosutinib—EPHB4—smooth muscle tissue—celiac disease	0.00119	0.00264	CbGeAlD
Bosutinib—MAP4K4—blood—celiac disease	0.00119	0.00264	CbGeAlD
Bosutinib—SIK3—liver—celiac disease	0.00119	0.00263	CbGeAlD
Bosutinib—IRAK1—pancreas—celiac disease	0.00119	0.00263	CbGeAlD
Bosutinib—HCK—digestive system—celiac disease	0.00118	0.00262	CbGeAlD
Bosutinib—CLK1—digestive system—celiac disease	0.00118	0.00262	CbGeAlD
Bosutinib—NUAK2—blood—celiac disease	0.00118	0.00262	CbGeAlD
Bosutinib—BCR—blood—celiac disease	0.00118	0.00262	CbGeAlD
Bosutinib—MAP3K12—blood—celiac disease	0.00117	0.0026	CbGeAlD
Bosutinib—FYN—smooth muscle tissue—celiac disease	0.00117	0.00258	CbGeAlD
Bosutinib—RPS6KB1—pancreas—celiac disease	0.00116	0.00258	CbGeAlD
Bosutinib—CAMK2G—digestive system—celiac disease	0.00116	0.00257	CbGeAlD
Bosutinib—YES1—connective tissue—celiac disease	0.00115	0.00255	CbGeAlD
Bosutinib—MAP2K1—blood—celiac disease	0.00115	0.00255	CbGeAlD
Bosutinib—CSK—blood—celiac disease	0.00114	0.00253	CbGeAlD
Bosutinib—STK4—liver—celiac disease	0.00114	0.00253	CbGeAlD
Bosutinib—MAP4K5—smooth muscle tissue—celiac disease	0.00114	0.00252	CbGeAlD
Bosutinib—PTK2B—lymphoid tissue—celiac disease	0.00114	0.00251	CbGeAlD
Bosutinib—TAOK3—connective tissue—celiac disease	0.00114	0.00251	CbGeAlD
Bosutinib—CSNK1A1—blood—celiac disease	0.00114	0.00251	CbGeAlD
Bosutinib—CAMK1D—liver—celiac disease	0.00113	0.0025	CbGeAlD
Bosutinib—HCK—blood—celiac disease	0.00113	0.0025	CbGeAlD
Bosutinib—CLK1—blood—celiac disease	0.00113	0.0025	CbGeAlD
Bosutinib—PTK2B—digestive system—celiac disease	0.00112	0.00248	CbGeAlD
Bosutinib—ABL2—blood—celiac disease	0.00112	0.00248	CbGeAlD
Bosutinib—STK24—liver—celiac disease	0.00112	0.00247	CbGeAlD
Bosutinib—SLK—pancreas—celiac disease	0.00111	0.00245	CbGeAlD
Bosutinib—SRC—connective tissue—celiac disease	0.00111	0.00245	CbGeAlD
Bosutinib—CAMK2G—blood—celiac disease	0.00111	0.00245	CbGeAlD
Bosutinib—BMP2K—blood—celiac disease	0.00111	0.00245	CbGeAlD
Bosutinib—CSNK1E—digestive system—celiac disease	0.00111	0.00244	CbGeAlD
Bosutinib—EPHB4—pancreas—celiac disease	0.0011	0.00244	CbGeAlD
Bosutinib—SIK1—lymphoid tissue—celiac disease	0.0011	0.00244	CbGeAlD
Bosutinib—IRAK4—lymphoid tissue—celiac disease	0.0011	0.00244	CbGeAlD
Bosutinib—LRRK2—blood—celiac disease	0.0011	0.00243	CbGeAlD
Bosutinib—EPHA2—pancreas—celiac disease	0.00108	0.00239	CbGeAlD
Bosutinib—FER—liver—celiac disease	0.00108	0.00239	CbGeAlD
Bosutinib—ERBB3—lymphoid tissue—celiac disease	0.00108	0.00239	CbGeAlD
Bosutinib—MAP2K2—lymphoid tissue—celiac disease	0.00108	0.00238	CbGeAlD
Bosutinib—LYN—liver—celiac disease	0.00107	0.00238	CbGeAlD
Bosutinib—PTK2B—blood—celiac disease	0.00107	0.00237	CbGeAlD
Bosutinib—MAP3K2—lymphoid tissue—celiac disease	0.00107	0.00236	CbGeAlD
Bosutinib—ERBB3—digestive system—celiac disease	0.00107	0.00236	CbGeAlD
Bosutinib—MAP2K2—digestive system—celiac disease	0.00106	0.00235	CbGeAlD
Bosutinib—ULK3—digestive system—celiac disease	0.00106	0.00235	CbGeAlD
Bosutinib—MAP4K5—pancreas—celiac disease	0.00105	0.00233	CbGeAlD
Bosutinib—YES1—smooth muscle tissue—celiac disease	0.00105	0.00233	CbGeAlD
Bosutinib—BTK—liver—celiac disease	0.00105	0.00233	CbGeAlD
Bosutinib—CSNK1E—blood—celiac disease	0.00105	0.00233	CbGeAlD
Bosutinib—SRC—epithelium—celiac disease	0.00105	0.00233	CbGeAlD
Bosutinib—TBK1—lymphoid tissue—celiac disease	0.00105	0.00232	CbGeAlD
Bosutinib—PTK2—lymphoid tissue—celiac disease	0.00105	0.00232	CbGeAlD
Bosutinib—TNK2—liver—celiac disease	0.00104	0.0023	CbGeAlD
Bosutinib—SIK1—blood—celiac disease	0.00104	0.00229	CbGeAlD
Bosutinib—IRAK4—blood—celiac disease	0.00104	0.00229	CbGeAlD
Bosutinib—PTK2—digestive system—celiac disease	0.00103	0.00229	CbGeAlD
Bosutinib—TBK1—digestive system—celiac disease	0.00103	0.00229	CbGeAlD
Bosutinib—EPHA4—blood—celiac disease	0.00103	0.00227	CbGeAlD
Bosutinib—MAP4K2—liver—celiac disease	0.00102	0.00226	CbGeAlD
Bosutinib—SRC—smooth muscle tissue—celiac disease	0.00101	0.00224	CbGeAlD
Bosutinib—MAP2K2—blood—celiac disease	0.00101	0.00224	CbGeAlD
Bosutinib—ULK3—blood—celiac disease	0.00101	0.00224	CbGeAlD
Bosutinib—STK3—liver—celiac disease	0.00101	0.00223	CbGeAlD
Bosutinib—RPS6KB1—lymphoid tissue—celiac disease	0.00101	0.00223	CbGeAlD
Bosutinib—MAP3K2—blood—celiac disease	0.00101	0.00222	CbGeAlD
Bosutinib—FGR—lymphoid tissue—celiac disease	0.001	0.00221	CbGeAlD
Bosutinib—AXL—lymphoid tissue—celiac disease	0.000997	0.0022	CbGeAlD
Bosutinib—ROCK1—liver—celiac disease	0.000997	0.0022	CbGeAlD
Bosutinib—MAP3K7—blood—celiac disease	0.000997	0.0022	CbGeAlD
Bosutinib—RPS6KB1—digestive system—celiac disease	0.000995	0.0022	CbGeAlD
Bosutinib—CSF1R—connective tissue—celiac disease	0.000995	0.0022	CbGeAlD
Bosutinib—FGR—digestive system—celiac disease	0.000989	0.00219	CbGeAlD
Bosutinib—PTK2—blood—celiac disease	0.000985	0.00218	CbGeAlD
Bosutinib—TBK1—blood—celiac disease	0.000985	0.00218	CbGeAlD
Bosutinib—YES1—pancreas—celiac disease	0.000974	0.00215	CbGeAlD
Bosutinib—BMPR2—liver—celiac disease	0.000968	0.00214	CbGeAlD
Bosutinib—IRAK1—blood—celiac disease	0.000966	0.00214	CbGeAlD
Bosutinib—TAOK3—pancreas—celiac disease	0.000962	0.00213	CbGeAlD
Bosutinib—STK36—liver—celiac disease	0.000961	0.00212	CbGeAlD
Bosutinib—MERTK—liver—celiac disease	0.000949	0.0021	CbGeAlD
Bosutinib—RPS6KB1—blood—celiac disease	0.000948	0.0021	CbGeAlD
Bosutinib—FGR—blood—celiac disease	0.000942	0.00208	CbGeAlD
Bosutinib—LCK—blood—celiac disease	0.000942	0.00208	CbGeAlD
Bosutinib—EPHB4—digestive system—celiac disease	0.000941	0.00208	CbGeAlD
Bosutinib—SRC—pancreas—celiac disease	0.000937	0.00207	CbGeAlD
Bosutinib—EPHA2—lymphoid tissue—celiac disease	0.000935	0.00207	CbGeAlD
Bosutinib—FYN—lymphoid tissue—celiac disease	0.000933	0.00206	CbGeAlD
Bosutinib—MAP4K4—liver—celiac disease	0.000932	0.00206	CbGeAlD
Bosutinib—BCR—liver—celiac disease	0.000925	0.00205	CbGeAlD
Bosutinib—NUAK2—liver—celiac disease	0.000925	0.00205	CbGeAlD
Bosutinib—EPHA2—digestive system—celiac disease	0.000923	0.00204	CbGeAlD
Bosutinib—FYN—digestive system—celiac disease	0.000922	0.00204	CbGeAlD
Bosutinib—MAP3K12—liver—celiac disease	0.000919	0.00203	CbGeAlD
Bosutinib—MAP4K5—lymphoid tissue—celiac disease	0.000912	0.00202	CbGeAlD
Bosutinib—CSF1R—smooth muscle tissue—celiac disease	0.00091	0.00201	CbGeAlD
Bosutinib—SLK—blood—celiac disease	0.000903	0.002	CbGeAlD
Bosutinib—MAP2K1—liver—celiac disease	0.0009	0.00199	CbGeAlD
Bosutinib—STK35—liver—celiac disease	0.0009	0.00199	CbGeAlD
Bosutinib—EPHB4—blood—celiac disease	0.000897	0.00198	CbGeAlD
Bosutinib—CSK—liver—celiac disease	0.000894	0.00198	CbGeAlD
Bosutinib—CSNK1A1—liver—celiac disease	0.000888	0.00196	CbGeAlD
Bosutinib—HCK—liver—celiac disease	0.000883	0.00195	CbGeAlD
Bosutinib—CLK1—liver—celiac disease	0.000883	0.00195	CbGeAlD
Bosutinib—PDGFRB—connective tissue—celiac disease	0.000882	0.00195	CbGeAlD
Bosutinib—EPHA2—blood—celiac disease	0.00088	0.00195	CbGeAlD
Bosutinib—FYN—blood—celiac disease	0.000878	0.00194	CbGeAlD
Bosutinib—ABL2—liver—celiac disease	0.000877	0.00194	CbGeAlD
Bosutinib—CAMK2G—liver—celiac disease	0.000866	0.00192	CbGeAlD
Bosutinib—BMP2K—liver—celiac disease	0.000866	0.00192	CbGeAlD
Bosutinib—LRRK2—liver—celiac disease	0.000859	0.0019	CbGeAlD
Bosutinib—MAP4K5—blood—celiac disease	0.000858	0.0019	CbGeAlD
Bosutinib—MAP3K3—blood—celiac disease	0.000858	0.0019	CbGeAlD
Bosutinib—EGFR—liver—celiac disease	0.000856	0.00189	CbGeAlD
Bosutinib—YES1—lymphoid tissue—celiac disease	0.000842	0.00186	CbGeAlD
Bosutinib—PDGFRB—epithelium—celiac disease	0.000838	0.00185	CbGeAlD
Bosutinib—PTK2B—liver—celiac disease	0.000837	0.00185	CbGeAlD
Bosutinib—STK10—lymphoid tissue—celiac disease	0.000835	0.00185	CbGeAlD
Bosutinib—YES1—digestive system—celiac disease	0.000832	0.00184	CbGeAlD
Bosutinib—TAOK3—lymphoid tissue—celiac disease	0.000831	0.00184	CbGeAlD
Bosutinib—STK10—digestive system—celiac disease	0.000824	0.00182	CbGeAlD
Bosutinib—CSNK1E—liver—celiac disease	0.000823	0.00182	CbGeAlD
Bosutinib—TAOK3—digestive system—celiac disease	0.000821	0.00182	CbGeAlD
Bosutinib—SIK1—liver—celiac disease	0.00081	0.00179	CbGeAlD
Bosutinib—IRAK4—liver—celiac disease	0.00081	0.00179	CbGeAlD
Bosutinib—SRC—lymphoid tissue—celiac disease	0.00081	0.00179	CbGeAlD
Bosutinib—PDGFRB—smooth muscle tissue—celiac disease	0.000807	0.00178	CbGeAlD
Bosutinib—SRC—digestive system—celiac disease	0.0008	0.00177	CbGeAlD
Bosutinib—ERBB3—liver—celiac disease	0.000794	0.00176	CbGeAlD
Bosutinib—YES1—blood—celiac disease	0.000793	0.00175	CbGeAlD
Bosutinib—ULK3—liver—celiac disease	0.000792	0.00175	CbGeAlD
Bosutinib—MAP2K2—liver—celiac disease	0.000792	0.00175	CbGeAlD
Bosutinib—MAP3K2—liver—celiac disease	0.000787	0.00174	CbGeAlD
Bosutinib—ABL1—connective tissue—celiac disease	0.000786	0.00174	CbGeAlD
Bosutinib—STK10—blood—celiac disease	0.000785	0.00174	CbGeAlD
Bosutinib—TAOK3—blood—celiac disease	0.000782	0.00173	CbGeAlD
Bosutinib—MAP3K7—liver—celiac disease	0.000779	0.00172	CbGeAlD
Bosutinib—PTK2—liver—celiac disease	0.000771	0.0017	CbGeAlD
Bosutinib—TBK1—liver—celiac disease	0.000771	0.0017	CbGeAlD
Bosutinib—SRC—blood—celiac disease	0.000762	0.00169	CbGeAlD
Bosutinib—IRAK1—liver—celiac disease	0.000755	0.00167	CbGeAlD
Bosutinib—PDGFRB—pancreas—celiac disease	0.000746	0.00165	CbGeAlD
Bosutinib—RPS6KB1—liver—celiac disease	0.000741	0.00164	CbGeAlD
Bosutinib—FGR—liver—celiac disease	0.000737	0.00163	CbGeAlD
Bosutinib—LCK—liver—celiac disease	0.000737	0.00163	CbGeAlD
Bosutinib—AXL—liver—celiac disease	0.000734	0.00162	CbGeAlD
Bosutinib—CSF1R—lymphoid tissue—celiac disease	0.000727	0.00161	CbGeAlD
Bosutinib—ABL1—smooth muscle tissue—celiac disease	0.000719	0.00159	CbGeAlD
Bosutinib—CSF1R—digestive system—celiac disease	0.000719	0.00159	CbGeAlD
Bosutinib—SLK—liver—celiac disease	0.000706	0.00156	CbGeAlD
Bosutinib—MAP2K5—blood—celiac disease	0.000701	0.00155	CbGeAlD
Bosutinib—EPHB4—liver—celiac disease	0.000701	0.00155	CbGeAlD
Bosutinib—EPHA2—liver—celiac disease	0.000688	0.00152	CbGeAlD
Bosutinib—FYN—liver—celiac disease	0.000687	0.00152	CbGeAlD
Bosutinib—CSF1R—blood—celiac disease	0.000685	0.00151	CbGeAlD
Bosutinib—MAP3K3—liver—celiac disease	0.000671	0.00148	CbGeAlD
Bosutinib—MAP4K5—liver—celiac disease	0.000671	0.00148	CbGeAlD
Bosutinib—ABL1—pancreas—celiac disease	0.000665	0.00147	CbGeAlD
Bosutinib—PDGFRB—lymphoid tissue—celiac disease	0.000645	0.00143	CbGeAlD
Bosutinib—PDGFRB—digestive system—celiac disease	0.000637	0.00141	CbGeAlD
Bosutinib—YES1—liver—celiac disease	0.00062	0.00137	CbGeAlD
Bosutinib—STK10—liver—celiac disease	0.000614	0.00136	CbGeAlD
Bosutinib—TAOK3—liver—celiac disease	0.000612	0.00135	CbGeAlD
Bosutinib—PDGFRB—blood—celiac disease	0.000607	0.00134	CbGeAlD
Bosutinib—SRC—liver—celiac disease	0.000596	0.00132	CbGeAlD
Bosutinib—ABL1—lymphoid tissue—celiac disease	0.000575	0.00127	CbGeAlD
Bosutinib—ABL1—digestive system—celiac disease	0.000568	0.00126	CbGeAlD
Bosutinib—MAP2K5—liver—celiac disease	0.000548	0.00121	CbGeAlD
Bosutinib—ABL1—blood—celiac disease	0.000541	0.0012	CbGeAlD
Bosutinib—CSF1R—liver—celiac disease	0.000535	0.00118	CbGeAlD
Bosutinib—PDGFRB—liver—celiac disease	0.000475	0.00105	CbGeAlD
Bosutinib—ABL1—liver—celiac disease	0.000423	0.000936	CbGeAlD
Bosutinib—CYP3A4—digestive system—celiac disease	0.00025	0.000552	CbGeAlD
Bosutinib—CYP3A4—blood—celiac disease	0.000238	0.000526	CbGeAlD
Bosutinib—ABCB1—epithelium—celiac disease	0.000232	0.000513	CbGeAlD
Bosutinib—ABCB1—pancreas—celiac disease	0.000207	0.000457	CbGeAlD
Bosutinib—CYP3A4—liver—celiac disease	0.000186	0.000411	CbGeAlD
Bosutinib—ABCB1—lymphoid tissue—celiac disease	0.000179	0.000395	CbGeAlD
Bosutinib—ABCB1—digestive system—celiac disease	0.000177	0.000391	CbGeAlD
Bosutinib—ABCB1—blood—celiac disease	0.000168	0.000372	CbGeAlD
Bosutinib—ABCB1—liver—celiac disease	0.000132	0.000291	CbGeAlD
Bosutinib—IRAK1—Signaling Pathways—CCR3—celiac disease	3.19e-05	5.83e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—HLA-DPB1—celiac disease	3.19e-05	5.82e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—HLA-DQA1—celiac disease	3.19e-05	5.82e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Adaptive Immune System—HLA-DRB1—celiac disease	3.19e-05	5.82e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—HLA-DQA1—celiac disease	3.18e-05	5.81e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—TNFAIP3—celiac disease	3.18e-05	5.8e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—HLA-DPB1—celiac disease	3.17e-05	5.79e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—HLA-DQB1—celiac disease	3.17e-05	5.78e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CTLA4—celiac disease	3.16e-05	5.78e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—CD8A—celiac disease	3.16e-05	5.77e-05	CbGpPWpGaD
Bosutinib—BLK—Immune System—HLA-DRB1—celiac disease	3.16e-05	5.76e-05	CbGpPWpGaD
Bosutinib—FGR—Immune System—HLA-DRB1—celiac disease	3.15e-05	5.74e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Innate Immune System—CD80—celiac disease	3.14e-05	5.74e-05	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—CD8A—celiac disease	3.14e-05	5.73e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—HLA-DPB1—celiac disease	3.14e-05	5.73e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—RGS1—celiac disease	3.13e-05	5.71e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—HLA-DPB1—celiac disease	3.12e-05	5.7e-05	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—HLA-DRB1—celiac disease	3.12e-05	5.7e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—FCGR2A—celiac disease	3.12e-05	5.69e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—CD8A—celiac disease	3.12e-05	5.69e-05	CbGpPWpGaD
Bosutinib—PTK2—Innate Immune System—CD4—celiac disease	3.12e-05	5.69e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—SH2B3—celiac disease	3.11e-05	5.68e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—PTPN2—celiac disease	3.1e-05	5.66e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CCR4—celiac disease	3.09e-05	5.64e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CTLA4—celiac disease	3.09e-05	5.64e-05	CbGpPWpGaD
Bosutinib—YES1—Innate Immune System—CD4—celiac disease	3.07e-05	5.61e-05	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—HLA-DRB1—celiac disease	3.07e-05	5.61e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—CD80—celiac disease	3.07e-05	5.6e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—TNFAIP3—celiac disease	3.06e-05	5.59e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Disease—CD4—celiac disease	3.06e-05	5.59e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Disease—CD4—celiac disease	3.06e-05	5.59e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—MBL2—celiac disease	3.05e-05	5.57e-05	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—CD80—celiac disease	3.03e-05	5.53e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—CTLA4—celiac disease	3.02e-05	5.52e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CD79A—celiac disease	3.02e-05	5.51e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CCR4—celiac disease	3.01e-05	5.5e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CTLA4—celiac disease	3.01e-05	5.49e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CCR3—celiac disease	3e-05	5.49e-05	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—CD80—celiac disease	3e-05	5.48e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—PTPN2—celiac disease	2.99e-05	5.46e-05	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—CD80—celiac disease	2.99e-05	5.46e-05	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—CD80—celiac disease	2.99e-05	5.45e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—HLA-DQB1—celiac disease	2.98e-05	5.44e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—HLA-DQB1—celiac disease	2.98e-05	5.44e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CTLA4—celiac disease	2.98e-05	5.43e-05	CbGpPWpGaD
Bosutinib—HCK—Disease—CD80—celiac disease	2.97e-05	5.42e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CTLA4—celiac disease	2.96e-05	5.4e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—CD8A—celiac disease	2.96e-05	5.4e-05	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—CD80—celiac disease	2.96e-05	5.4e-05	CbGpPWpGaD
Bosutinib—CSK—Disease—CD4—celiac disease	2.95e-05	5.39e-05	CbGpPWpGaD
Bosutinib—YES1—Adaptive Immune System—CD4—celiac disease	2.95e-05	5.39e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CCR4—celiac disease	2.95e-05	5.39e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CD79A—celiac disease	2.95e-05	5.38e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Adaptive Immune System—CD80—celiac disease	2.95e-05	5.38e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—CD80—celiac disease	2.94e-05	5.37e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—SH2B3—celiac disease	2.93e-05	5.35e-05	CbGpPWpGaD
Bosutinib—IRAK1—Innate Immune System—CD4—celiac disease	2.92e-05	5.32e-05	CbGpPWpGaD
Bosutinib—BLK—Immune System—CD80—celiac disease	2.92e-05	5.32e-05	CbGpPWpGaD
Bosutinib—FGR—Immune System—CD80—celiac disease	2.91e-05	5.3e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CCR4—celiac disease	2.9e-05	5.3e-05	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—HLA-DRB1—celiac disease	2.89e-05	5.28e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CCR4—celiac disease	2.89e-05	5.27e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—CD79A—celiac disease	2.88e-05	5.26e-05	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—CD80—celiac disease	2.88e-05	5.26e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CD79A—celiac disease	2.87e-05	5.24e-05	CbGpPWpGaD
Bosutinib—TBK1—Immune System—CD4—celiac disease	2.87e-05	5.24e-05	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—CD80—celiac disease	2.86e-05	5.22e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CD79A—celiac disease	2.84e-05	5.18e-05	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—CD80—celiac disease	2.84e-05	5.18e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CD79A—celiac disease	2.82e-05	5.16e-05	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—CD4—celiac disease	2.82e-05	5.14e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—CD80—celiac disease	2.81e-05	5.12e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—CD80—celiac disease	2.81e-05	5.12e-05	CbGpPWpGaD
Bosutinib—ERBB4—Disease—CD80—celiac disease	2.8e-05	5.11e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—HLA-DQA1—celiac disease	2.79e-05	5.09e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—CD8A—celiac disease	2.78e-05	5.08e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—CD8A—celiac disease	2.78e-05	5.08e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—RGS1—celiac disease	2.77e-05	5.06e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—FCGR2A—celiac disease	2.76e-05	5.04e-05	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—CD4—celiac disease	2.75e-05	5.02e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Innate Immune System—CD4—celiac disease	2.75e-05	5.01e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—HLA-DQA1—celiac disease	2.72e-05	4.96e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—HLA-DPB1—celiac disease	2.71e-05	4.95e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—TNFAIP3—celiac disease	2.71e-05	4.95e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—CD80—celiac disease	2.71e-05	4.95e-05	CbGpPWpGaD
Bosutinib—BTK—Immune System—CD4—celiac disease	2.68e-05	4.89e-05	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—CD80—celiac disease	2.67e-05	4.88e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—HLA-DQA1—celiac disease	2.66e-05	4.86e-05	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—HLA-DRB1—celiac disease	2.65e-05	4.85e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—HLA-DQA1—celiac disease	2.65e-05	4.84e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—PTPN2—celiac disease	2.65e-05	4.83e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Adaptive Immune System—CD4—celiac disease	2.64e-05	4.81e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CCR3—celiac disease	2.63e-05	4.79e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—HLA-DQA1—celiac disease	2.62e-05	4.78e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—HLA-DPB1—celiac disease	2.61e-05	4.77e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—HLA-DQA1—celiac disease	2.61e-05	4.76e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—HLA-DQB1—celiac disease	2.61e-05	4.76e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—HLA-DRB1—celiac disease	2.57e-05	4.7e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CTLA4—celiac disease	2.57e-05	4.69e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CCR3—celiac disease	2.56e-05	4.68e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—SH2B3—celiac disease	2.56e-05	4.67e-05	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—CD4—celiac disease	2.56e-05	4.67e-05	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—HLA-DRB1—celiac disease	2.56e-05	4.67e-05	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—CD80—celiac disease	2.55e-05	4.66e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—HLA-DQB1—celiac disease	2.54e-05	4.64e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—HLA-DRB1—celiac disease	2.54e-05	4.63e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CCR4—celiac disease	2.51e-05	4.58e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CCR3—celiac disease	2.51e-05	4.58e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—SH2B3—celiac disease	2.5e-05	4.56e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—HLA-DQB1—celiac disease	2.49e-05	4.54e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CTLA4—celiac disease	2.48e-05	4.52e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—HLA-DQB1—celiac disease	2.48e-05	4.52e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—CD4—celiac disease	2.47e-05	4.51e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CCR3—celiac disease	2.47e-05	4.51e-05	CbGpPWpGaD
Bosutinib—ERBB3—Disease—CD80—celiac disease	2.47e-05	4.5e-05	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—CD80—celiac disease	2.46e-05	4.49e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CCR3—celiac disease	2.46e-05	4.48e-05	CbGpPWpGaD
Bosutinib—HCK—Immune System—CD4—celiac disease	2.46e-05	4.48e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD79A—celiac disease	2.45e-05	4.48e-05	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—CD80—celiac disease	2.45e-05	4.48e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—HLA-DQB1—celiac disease	2.45e-05	4.47e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—SH2B3—celiac disease	2.44e-05	4.46e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—HLA-DQB1—celiac disease	2.44e-05	4.45e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CD8A—celiac disease	2.43e-05	4.44e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CCR4—celiac disease	2.42e-05	4.42e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—HLA-DRB1—celiac disease	2.41e-05	4.4e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—SH2B3—celiac disease	2.41e-05	4.39e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Innate Immune System—CD4—celiac disease	2.4e-05	4.38e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—SH2B3—celiac disease	2.39e-05	4.37e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—CD80—celiac disease	2.38e-05	4.34e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CD8A—celiac disease	2.37e-05	4.33e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD79A—celiac disease	2.36e-05	4.32e-05	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—CD80—celiac disease	2.36e-05	4.31e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—CD80—celiac disease	2.35e-05	4.28e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—LCT—celiac disease	2.34e-05	4.28e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—CD4—celiac disease	2.34e-05	4.27e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—CD8A—celiac disease	2.32e-05	4.24e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—HLA-DPB1—celiac disease	2.31e-05	4.22e-05	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—CD4—celiac disease	2.31e-05	4.22e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CD8A—celiac disease	2.31e-05	4.22e-05	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—CD4—celiac disease	2.29e-05	4.18e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CD8A—celiac disease	2.29e-05	4.18e-05	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—CD4—celiac disease	2.28e-05	4.17e-05	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—CD4—celiac disease	2.28e-05	4.16e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CD8A—celiac disease	2.28e-05	4.16e-05	CbGpPWpGaD
Bosutinib—HCK—Disease—CD4—celiac disease	2.27e-05	4.14e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—CD80—celiac disease	2.27e-05	4.14e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—HLA-DRB1—celiac disease	2.27e-05	4.14e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—HLA-DRB1—celiac disease	2.26e-05	4.13e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—HLA-DQA1—celiac disease	2.26e-05	4.13e-05	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—CD4—celiac disease	2.26e-05	4.12e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Adaptive Immune System—CD4—celiac disease	2.25e-05	4.1e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—CD4—celiac disease	2.24e-05	4.1e-05	CbGpPWpGaD
Bosutinib—BLK—Immune System—CD4—celiac disease	2.23e-05	4.06e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—CD80—celiac disease	2.22e-05	4.06e-05	CbGpPWpGaD
Bosutinib—FGR—Immune System—CD4—celiac disease	2.22e-05	4.05e-05	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—CD4—celiac disease	2.2e-05	4.02e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CTLA4—celiac disease	2.19e-05	4e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—HLA-DQA1—celiac disease	2.18e-05	3.98e-05	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—CD80—celiac disease	2.18e-05	3.98e-05	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—CD4—celiac disease	2.17e-05	3.96e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCR4—celiac disease	2.14e-05	3.91e-05	CbGpPWpGaD
Bosutinib—ERBB4—Disease—CD4—celiac disease	2.14e-05	3.9e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CCR3—celiac disease	2.13e-05	3.9e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—HLA-DQB1—celiac disease	2.12e-05	3.87e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—CD80—celiac disease	2.09e-05	3.82e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD79A—celiac disease	2.09e-05	3.82e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—CD80—celiac disease	2.09e-05	3.82e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—SH2B3—celiac disease	2.08e-05	3.8e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CCR3—celiac disease	2.06e-05	3.75e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—HLA-DQB1—celiac disease	2.04e-05	3.73e-05	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—CD4—celiac disease	2.04e-05	3.72e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—SH2B3—celiac disease	2e-05	3.66e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—HLA-DRB1—celiac disease	1.98e-05	3.62e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD8A—celiac disease	1.98e-05	3.61e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—CD80—celiac disease	1.96e-05	3.58e-05	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—CD4—celiac disease	1.95e-05	3.56e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—HLA-DRB1—celiac disease	1.93e-05	3.53e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—HLA-DQA1—celiac disease	1.93e-05	3.53e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—CD80—celiac disease	1.93e-05	3.53e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD8A—celiac disease	1.91e-05	3.48e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—HLA-DRB1—celiac disease	1.89e-05	3.46e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—HLA-DRB1—celiac disease	1.88e-05	3.44e-05	CbGpPWpGaD
Bosutinib—ERBB3—Disease—CD4—celiac disease	1.88e-05	3.44e-05	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—CD4—celiac disease	1.88e-05	3.43e-05	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—CD4—celiac disease	1.87e-05	3.42e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—HLA-DRB1—celiac disease	1.86e-05	3.4e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—CD80—celiac disease	1.86e-05	3.4e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—HLA-DRB1—celiac disease	1.85e-05	3.38e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CD80—celiac disease	1.83e-05	3.34e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCR3—celiac disease	1.82e-05	3.32e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—CD4—celiac disease	1.82e-05	3.31e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—HLA-DQB1—celiac disease	1.81e-05	3.3e-05	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—CD4—celiac disease	1.8e-05	3.29e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—CD80—celiac disease	1.79e-05	3.27e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—CD80—celiac disease	1.79e-05	3.27e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—CD4—celiac disease	1.79e-05	3.27e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CD80—celiac disease	1.79e-05	3.26e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—SH2B3—celiac disease	1.77e-05	3.24e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—CD80—celiac disease	1.75e-05	3.19e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CD80—celiac disease	1.74e-05	3.18e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—CD80—celiac disease	1.73e-05	3.15e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CD80—celiac disease	1.72e-05	3.14e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CD80—celiac disease	1.71e-05	3.13e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—CD4—celiac disease	1.7e-05	3.1e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—CD80—celiac disease	1.69e-05	3.09e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD8A—celiac disease	1.69e-05	3.08e-05	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—CD4—celiac disease	1.66e-05	3.04e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—CD80—celiac disease	1.65e-05	3.01e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—HLA-DRB1—celiac disease	1.61e-05	2.94e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—CD4—celiac disease	1.6e-05	2.92e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—CD4—celiac disease	1.6e-05	2.92e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—CD80—celiac disease	1.59e-05	2.9e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—CD80—celiac disease	1.58e-05	2.89e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—HLA-DRB1—celiac disease	1.55e-05	2.83e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CD80—celiac disease	1.54e-05	2.81e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CD80—celiac disease	1.52e-05	2.77e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD80—celiac disease	1.49e-05	2.72e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CD80—celiac disease	1.44e-05	2.63e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD80—celiac disease	1.43e-05	2.62e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CD4—celiac disease	1.4e-05	2.55e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—HLA-DRB1—celiac disease	1.37e-05	2.51e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—CD80—celiac disease	1.37e-05	2.51e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CD4—celiac disease	1.36e-05	2.49e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CD80—celiac disease	1.35e-05	2.47e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—CD4—celiac disease	1.34e-05	2.44e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CD4—celiac disease	1.33e-05	2.43e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—CD80—celiac disease	1.32e-05	2.42e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CD4—celiac disease	1.31e-05	2.4e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CD4—celiac disease	1.31e-05	2.39e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—CD4—celiac disease	1.29e-05	2.36e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD80—celiac disease	1.27e-05	2.32e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—CD4—celiac disease	1.26e-05	2.3e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—CD4—celiac disease	1.21e-05	2.22e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—CD4—celiac disease	1.21e-05	2.2e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CD80—celiac disease	1.18e-05	2.16e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—CD80—celiac disease	1.17e-05	2.14e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CD80—celiac disease	1.15e-05	2.11e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD4—celiac disease	1.14e-05	2.07e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CD80—celiac disease	1.13e-05	2.06e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CD80—celiac disease	1.11e-05	2.03e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CD80—celiac disease	1.11e-05	2.02e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD4—celiac disease	1.09e-05	2e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—CD4—celiac disease	1.05e-05	1.91e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—CD4—celiac disease	1.01e-05	1.84e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD4—celiac disease	9.69e-06	1.77e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CD80—celiac disease	9.62e-06	1.76e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CD80—celiac disease	9.27e-06	1.69e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—CD4—celiac disease	8.94e-06	1.63e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CD80—celiac disease	8.2e-06	1.5e-05	CbGpPWpGaD
